NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, reported today that it will exhibit at the American Diabetes Association’s (ADA) 74th Scientific Sessions. The ADA Scientific Sessions will be held on June 13-17 in San Francisco at the Moscone Center.
Help employers find you! Check out all the jobs and post your resume.
